Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
FWIW I dont think they should be trading on the London Market and TASE is too small so at some point they are going to have to move exchanges to NASDAQ. Thats will probably happen as Telco is already a US company.
This is a very real area of expansion for the company and there are several players looking seriously at this platform to manage quantum solutions. I cant say anymore about this other to say stock sensei comments are highly relevant.
The issue is with Iran. Hamas forcibly removed the Palestinian government in Gaza. Red Sea shipping routes are inoperable thanks to Iran. Trouble in Syria and Lebanon again Iran. Problems in Iraq well that would be Iran again. Of course Ukraine is hardly happy about the Iran component. Stop blaming Israel when it's clear to all what the "actual" problem is here.
It appears Edgility itself pulled in $15m in 2023. As this is cumulative revenue even if they put in a lacklustre performance 2024 est. 35M 2025 est. 55m. this is all very high margin. If you add this to the bottom line of a hopefully strong 2024 for Cyber and Medical Diagnostics then this all looks potentially a lot different. FWIW
Results were in line with expectations. There were quite a few positives in there albeit the general backdrop is tough. The company held their own and paid for R&D and extra cash for ADOR. It's hard to be objective about these results because they have no contribution from ADOR and very little from Edgility sales (yet). The 2 most potentially disruptive IP they have are not contributing revenue. My take is that it is happening but not at the speed investors wanted.
Link posted on other thread worth looking at.
https://www.edgeir.com/?posttype=all&s=Telco+systems
Https://www.jpost.com/business-and-innovation/article-779622
BATM theatre of operations is largely outside of Israel. Adaltis in Italy and Telco systems is a US company.
Edgility is making waves in edge computing. With newfound support for Kubernetes, Docker, and Kubevirt agents at the edge, it’s not just keeping up; it’s taking the lead. Imagine deploying a mix of workloads effortlessly, seamlessly blending containers and virtual machines across the edge landscape – no drama, just efficiency. Now boasting management and control for AI acceleration, Edgility is your go-to solution for implementing AI and ML based applications at the edge. With Active/Active High-Availability Manager, Edgility ensures operations stay on track, emphasizing reliability when the going gets tough.
It’s been an absurd situation here ever since the end of the pandemic. BATM is a unique situation where they actually do enough regular business to fund their emerging IP. Let’s say you took all the research and development money they spend on this and added it to their bottom line then the company would be highly profitable. They had no problem topping up their investment with ADOR with a few million and incidentally increasing their % holding. Telco systems also sell sufficient mainstream kit to keep funding Edgility.
The value of their IP is not reflected in the SP at all.
There are several reasons without stating the obvious that Investors are shunning Israeli and other Tech stocks. When you can get 5% to 6% on your money sitting on the sidelines why risk anything. I referenced the shift in perception from IP worth to revenue growth and this is another limiter. If BATM are able to demonstrate meaningful revenue growth with the new technologies they have been developing in house with no dilution to shareholders, then we will likely see some action. It’s unlikely they will miss end of year expectations so it’s a matter of accumulating a few whilst the SP is so absurdly undervalued.
BATM companies are all located outside of Israel but they will nevertheless face some staffing issues at head office which they have already indicated they can work around.
Edgility have been making presentation around the globe and often with partners. The latest being Nov 7th to 9th in Barcelona. Edge computing solutions and the architecture to have them function is a buzz word in the industry.
Telco systems also ought to be making money out of Ethernet back haul systems which they have considerable experience with.
Cyber is another area that is very much in demand.
I agree with stock sense that the price will likely stew but the move will likely be extreme when it comes. The company is well financed so it really IMO is a matter of “when” not “if” and it may be difficult to even get stock as every few days we get a large trading volume above 1M shares which indicates to me that there are some larger investors taking shares away from the skittish at bargain prices.
One of the big issues with BATM share price has been valuing their IP. It is an integral part of overall valuation and the SP trended very much higher than today on the perception that they would sell either the medical or Telco arm for fairly large amounts. BATM decided to keep both of these divisions rather than sell them off which in turn means that the SP is judged on revenue more than IP. It’s now likely that the company will divest itself of non core assets and these will top up the coffers but not to the degree of selling one of the main divisions. So we have a situation that based on pure revenue the company is still undervalued by some 70% according to Simply Wall Street and fundamentals analysis. If Edgility and ADOR start generating revenue it will come on top of these fundamentals sales and you have a whole different ball game.
BATM are not alone in getting the treatment. A client of theirs Israeli Audio Codes in this file is also trading at around 20% of their historic value in spite of turning in reasonable sales figures. BATM revenue last period was ahead of pre Covid numbers when you strip out Covid test kit sales. All divisions are in profit and there are new revenue streams starting to be seen in the bottom line. The shares have been hideously manipulated but they can’t do it for ever. I have not seen a single analyst report that says they are not very undervalued. The company has adequate funding to bring this new technology to market and in this environment that’s a big deal.
It's probably not a bad metric to equate BATM entire market cap X? with the value of the equity share they have with ADOR. Rest of the company for nothing. We do have a war in Israel and the head offices are there but the largest interests are outside the country.
This is not being developed in Israel and is a partnership from 10 years ago between Gamida and Adaltis.
It's in the latter stages of development. Rolling circle amplification is not new but getting it to work is. RCA speeds up diagnostic time, is more sensitive and precise. The ultimate goal is to get the diagnosis matched with a treatment. The cost and time saved for the health services is substantial.